# OnCo record mersana (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mersana/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mersana" ;
  schema:name "Mersana Therapeutics"@en ;
  schema:description "ADC platform company betting on B7-H4: emiltatug ledadotin (Emi-Le) has Breakthrough designation in adenoid cystic carcinoma and activity in TNBC after TOP1 ADCs."@en ;
  schema:url <https://onco.cc/companies/mersana/>, <https://www.mersana.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.onclive.com/view/fda-grants-breakthrough-therapy-designation-to-emi-le-for-adenoid-cystic-carcinoma> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/immune-stimulating-adc/> ;
  onco:drugs <https://onco.cc/drugs/upifitamab-rilsodotin/> ;
  onco:terms <https://onco.cc/terms/adc-sequencing/> .